UPDATE - UBS Initiates Coverage on Kroger (KR) with a Neutral; Executing Properly, But Shares Fairly Valued
Get Alerts KR Hot Sheet
Price: $57.90 +2.81%
Rating Summary:
16 Buy, 19 Hold, 4 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Rating Summary:
16 Buy, 19 Hold, 4 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Join SI Premium – FREE
UPDATE - UBS initiates coverage on Kroger (NYSE: KR) with a Neutral rating. PT $25.
UBS analyst said, "Since the early 2000s, Kroger has continued to reduce its gross margin to drive market share gains. The strategy has worked very well, as its comparable sales growth has averaged 4% per year over the last 5 years, vs. Safeway (NYSE: SWY) at 0% and SUPERVALU (NYSE: SVU) at -3%. Despite the intentional reduction in gross margin, its comparable gross profit CAGR was 3%, allowing it to deliver 5% EPS CAGR in a very difficult period for conventional food retailers."
The analyst expects more of the same price commitments over the next five years and feels (as a bullish case) that KR has the opportunity to take growth to the next level (by rolliing out Fresh Fare and Food 4 Less to more markets).
To see more ratings on KR, Click Here
UBS analyst said, "Since the early 2000s, Kroger has continued to reduce its gross margin to drive market share gains. The strategy has worked very well, as its comparable sales growth has averaged 4% per year over the last 5 years, vs. Safeway (NYSE: SWY) at 0% and SUPERVALU (NYSE: SVU) at -3%. Despite the intentional reduction in gross margin, its comparable gross profit CAGR was 3%, allowing it to deliver 5% EPS CAGR in a very difficult period for conventional food retailers."
The analyst expects more of the same price commitments over the next five years and feels (as a bullish case) that KR has the opportunity to take growth to the next level (by rolliing out Fresh Fare and Food 4 Less to more markets).
To see more ratings on KR, Click Here
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- DA Davidson Starts Everus (ECG) at Buy
- Needham Starts Faeth Therapeutics (FTH) at Buy
- Wells Fargo Starts Vivmark Residential (VMRK) at Overweight, 'Setting the mark for growth'
Create E-mail Alert Related Categories
New CoverageRelated Entities
UBSSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share